Supports collaborative translational research between external researchers and NIH investigators at the NIH Clinical Center to advance understanding of disease, treatments, diagnostics, and prevention.
Funder: National Institutes of Health
Due Dates: October 31, 2026 (Support letter requests) | February 5, 2027 (New applications) | March 5, 2027 (Renewals/resubmissions/revisions) | March 6, 2027 (Expiration)
Funding Amounts: Up to $500,000 in direct costs annually for four years, or five with a reduced-budget planning year
Summary: Supports patient-centric translational research partnerships between extramural investigators and NIH intramural scientists using the NIH Clinical Center.
Key Information: Patients must be seen at the NIH Clinical Center; projects using only banked samples or data are ineligible.
This NIH U01 cooperative agreement supports collaborative translational research that advances basic biological discoveries toward clinical applications. Projects should improve understanding of important disease processes or develop therapeutic interventions, diagnostics, or prevention strategies within participating NIH Institutes’ and Centers’ research priorities. Clinical trials are optional.
The program connects external researchers with NIH intramural investigators and the Clinical Center’s specialized resources, expertise, and infrastructure. These include rare-disease cohorts, imaging and PET ligand development, specialized therapies, and support for challenging clinical studies that may not be readily supported elsewhere. Teams must meaningfully use Clinical Center resources and see patients there, although some participants may also be seen at extramural sites.